Original Article

Pneumonectomy for Non–Small Cell Lung Cancer: Outcomes Analysis

Authors: Rohan J. Kalathiya, BS, Sibu P. Saha, MD, MBA

Abstract

Objective: The purpose of this study was to investigate the morbidity and mortality of 100 consecutive patients with pneumonectomy for non–small cell lung cancer at the University of Kentucky.


Methods: We retrospectively reviewed the medical records of 100 consecutive pneumonectomy patients, 1998–2009.


Results: The median age of patients was 59 years, with a range of 27 to 79 years. Sixty-eight patients (68%) were men. Fifty-four patients (54%) received left pneumonectomy. Major postoperative complication rate was 39%, with atrial fibrillation being the most common complication, occurring in 26 patients. The overall postoperative mortality rate was 11% (11/100 patients). The mortality rate among right pneumonectomy patients was 17.4% (8/46 patients) compared with 5.6% (3/54 patients) for left pneumonectomy. The postoperative mortality rate among patients receiving neoadjuvant therapy was 14.3% (4/28 patients). In addition, among patients who received neoadjuvant therapy, the mortality rate for right and left pneumonectomy was 21.4% (3/14 patients) and 7.1% (1/14 patients), respectively. The mortality rate among patients older than 70 years at the time of pneumonectomy was 18.2% (2/11 patients).


Conclusions: With a postoperative mortality rate of 11% and a major postoperative complication rate of 39%, pneumonectomy for non–small cell lung cancer is associated with high morbidity and mortality. The factors associated with the increased mortality rate include right pneumonectomy, patient age older than 70 years at the time of procedure, and neoadjuvant therapy before pneumonectomy.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

 
2. Alexiou C, Beggs D, Rogers ML, et al. Pneumonectomy for non-small cell lung cancer: predictors of operative mortality and survival. Eur J Cardiothorac Surg 2001; 20: 476–480.
 
3. Romano PS, Mark DH. Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest 1992; 101: 1332–1337.
 
4. Bernard A, Deschamps C, Allen MS, et al. Pneumonectomy for malignant disease: factors affecting early morbidity and mortality. J Thorac Cardiovasc Surg 2001; 121: 1076–1082.
 
5. Licker M, Spiliopoulos A, Frey JG, et al. Risk factors for early mortality and major complications following pneumonectomy for non-small cell carcinoma of the lung. Chest 2001; 121: 1890–1897.
 
6. Rostad H, Strand TE, Naalsund A, et al. Lung cancer surgery: the first 60 days. A population-based study. Eur J Cardiothorac Surg 2006; 29: 824–828.
 
7. Ramnath N, Demmy TL, Antun A, et al. Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting survival. Ann Thorac Surg 2007; 83: 1831–1836.
 
8. Powell ES, Pearce AC, Cook D, et al. UK pneumonectomy outcome study (UKPOS): a prospective observational study of pneumonectomy outcome. J Cardiothorac Surg 2009; 4: 41.
 
9. Marret E, Miled F, Bazelly B, et al. Risk and protective factors for major complications after pneumonectomy for lung cancer. Interact Cardiovasc Thorac Surg 2010; 10: 936–939.
 
10. Alloubi I, Jougon J, Delcambre F, et al. Early complications after pneumonectomy: retrospective study of 168 patients. Interact Cardiovasc Thorac Surg 2010; 11: 162–165.
 
11. Sartipy U. Prospective population-based study comparing quality of life after pneumonectomy and lobectomy. Eur J Cardiothorac Surg 2009; 36: 1069–1074.
 
12. Darling GE, Abdurahman A, Yi QL, et al. Risk of a right pneumonectomy: role of bronchopleural fistula. Ann Thorac Surg 2005; 79: 433–437.
 
13. Fowler WC, Langer CJ, Curran WJ Jr, et al. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 1993; 55: 986–989.
 
14. Venuta F, Anile M, Diso D, et al. Operative complications and early mortality after induction therapy for lung cancer. Eur J Cardiothorac Surg 2007; 31: 714–717.
 
15. Daly BD, Fernando HC, Ketchedjian A, et al. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer. Ann Thorac Surg 2006; 82: 227–231.
 
16. Ng T, Birnbaum AE, Fontaine JP, et al. Pneumonectomy after neoadjuvant chemotherapy and radiation for advanced-stage lung cancer. Ann Surg Oncol 2010; 17: 476–482.
 
17. Alan S, Jan S, Tomas H, et al. Does chemotherapy increase morbidity and mortality after pneumonectomy? J Surg Oncol 2009; 99: 38–41.
 
18. Doddoli C, Barlesi F, Trousse D, et al. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits. J Thorac Cardiovasc Surg 2005; 130: 416–425.
 
19. Martin J, Ginsberg RJ, Abolhoda A, et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 2001; 72: 1149–1154.
 
20. Groenendijk RP, Croiset van Uchelen FA, Mol SJ, et al. Factors related to outcome after pneumonectomy: retrospective study of 62 patients. Eur J Surg 1999; 165: 193–197.